COVID-19 Origin Act of 2023
Summary
The COVID-19 Origin Act of 2023 (S. 619) was signed into law on March 20, 2023, requiring the ODNI to declassify and report on information linking the Wuhan Institute of Virology to COVID-19's origin. It authorizes no funding and imposes no regulatory or procurement mandates on any private sector company, making it a transparency and national security policy action with no direct market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The bill is fully enacted and imposes no spending, contracts, or regulatory requirements on any private sector company.
- 2.No publicly traded company is directly or indirectly affected by this declassification mandate.
- 3.Investors should not expect any market movement from this legislation; it is a transparency policy with zero financial impact.
Market Implications
There are no market implications from this bill. It does not authorize spending, create procurement programs, impose taxes or fees, or alter any regulatory framework affecting publicly traded companies. Investors should not allocate capital based on this legislation.
Full Analysis
The COVID-19 Origin Act of 2023 was introduced by Sen. Josh Hawley (R-MO) on March 1, 2023, passed the Senate by unanimous consent the same day, passed the House on March 10, and was signed into law by The President on March 20, 2023 (Public Law 118-2). The bill is now fully enacted and requires no further legislative action. It mandates the Director of National Intelligence to declassify all information relating to potential links between the Wuhan Institute of Virology and the origin of COVID-19, and to submit an unclassified report to Congress within 90 days, with redactions only to protect sources and methods. The bill includes a Sense of Congress stating that identifying COVID-19's origin is critical for future pandemic prevention and that there is reason to believe the pandemic may have originated at the Wuhan Institute of Virology. The bill authorizes zero dollars in spending—it is a declassification and reporting mandate, not a procurement, grant, or tax incentive program. There is no funding mechanism, no contract vehicle, and no regulatory change that affects any private sector company's revenue, costs, or competitive position. The bill's policy area is Armed Forces and National Security, but it is a transparency and intelligence-reporting action, not a defense procurement or military operations bill. No publicly traded company is named in the bill text, and no company's business model is directly or indirectly affected by the declassification requirement. The bill has no convergence with any procurement, executive action, or other legislative signal that would create a shared government objective affecting private markets. The legislative timeline is complete—the bill is law and has been executed. No further steps remain.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
HII MISSION TECHNOLOGIES CORP: $676M General Services Administration Contract
VERTEX AEROSPACE LLC: $571M General Services Administration Contract
HII MISSION TECHNOLOGIES CORP: $666M General Services Administration Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
HII MISSION TECHNOLOGIES CORP: $638M General Services Administration Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Securing America’s Defense Supply Chains and Ensuring Domestic Acquisition of Critical Materials
This executive order restricts waivers for foreign-sourced critical materials in defense contracts, effective January 1, 2027, and mandates that defense contractors map their supply chains from raw materials to end products, vet subcontractors for risks, and prohibit covered materials from unreliable foreign suppliers. It directs the Secretary of War to enforce strict compliance, including requiring mitigation plans for any non-compliant materials and establishing penalties for fraud or willful noncompliance.
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Ushering in the Next Frontier of Quantum Innovation
This executive order updates the National Quantum Strategy and establishes a national effort (QC-ADDS) to develop a quantum computer for scientific discovery, with deployment at a Department of Energy facility. It directs multiple agencies to prioritize quantum sensing, networking, and supply chain initiatives, and mandates plans for commercial readiness and national security applications.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →